Ruxolitinib Cream Shows Long-Term Disease Control, Efficacy Among Adolescents with Eczema
These data highlight the safety, efficacy, and long-term disease control results of treatment with topical ruxolitinib for a subpopulation of adolescents with atopic dermatitis.